EXPLAINER: Final steps in US review of COVID-19 vaccine
4 years ago

EXPLAINER: Final steps in US review of COVID-19 vaccine

Associated Press  

WASHINGTON — Pfizer’s COVID-19 vaccine is entering the final phase of review before the U.S. government decides whether to allow millions to get the shots. A look at the process: FDA REVIEW The agency’s scientific review is a key step — not just for the U.S. — but for countries around the world weighing whether to begin using a vaccine. FDA Commissioner Stephen Hahn says that careful approach carries weight far beyond the U.S. “The FDA is known around the world for its rigorous standards for safety and efficacy,” Hahn told The Associated Press. “I think you’ll see with the data we’re going to provide at the meeting that we have done our job.” VACCINE EXPERT MEETING Next, a group of about two dozen outside experts weighs in on the FDA’s findings and gives their own assessment.

History of this topic

As COVID-19 ticks up in some places, US advisers recommend a fall vaccination campaign
5 months, 3 weeks ago
2% of kids and 7% of adults have gotten the new COVID shots, US data show
1 year, 1 month ago
Updated COVID vaccines will be available later this week, recommended for everyone six months and up
1 year, 3 months ago
US FDA authorizes Pfizer-BioNTech, Moderna's updated Covid shots
1 year, 3 months ago
U.S. approves updated COVID vaccines to rev up protection this fall
1 year, 3 months ago
US approves updated COVID vaccines to rev up protection this fall
1 year, 3 months ago
FDA approves updated COVID vaccines to rev up protection this fall
1 year, 3 months ago
Next round of COVID-19 shots in fall will target latest omicron strain
1 year, 6 months ago
An FDA panel meets about which COVID strains the U.S. will target with vaccines
1 year, 6 months ago
How Matt Hancock sought to hog the Covid vaccine limelight
1 year, 9 months ago
FDA panel narrowly backs Pfizer RSV vaccine for older adults
1 year, 9 months ago
FDA advisers set to consider one-and-done annual covid booster plan
1 year, 10 months ago
FDA wants to simplify the use and updating of Covid-19 vaccines
1 year, 11 months ago
FDA vaccine advisers ‘disappointed’ and ‘angry’ that early data about new Covid-19 booster shot wasn’t presented for review last year
1 year, 11 months ago
report highlights irregularities in FDA approval of COVID-19 vaccines, drugs
2 years ago
Panel votes to add COVID shots to recommended vaccinations
2 years, 2 months ago
Panel votes to add COVID shots to recommended vaccinations
2 years, 2 months ago
Covid-19 vaccination campaign held back by poor planning, safety board finds
2 years, 2 months ago
Covid-19 vaccination campaign held back by poor planning, safety board finds
2 years, 2 months ago
US CDC endorses updated Covid boosters, shots to begin soon
2 years, 3 months ago
FDA grapples with whether to modify COVID vaccine for fall
2 years, 5 months ago
US opens COVID vaccine to little kids; shots begin this week
2 years, 6 months ago
US to roll out COVID vaccines for youngest children next week
2 years, 6 months ago
FDA advisers vote in favor of authorizing Covid-19 vaccines for children as young as 6 months
2 years, 6 months ago
The AP Interview: US ‘vulnerable’ to COVID without new shots
2 years, 7 months ago
FDA sets June meetings on COVID vaccines for youngest kids
2 years, 7 months ago
CDC backs Moderna COVID-19 shots after full US approval
2 years, 10 months ago
US gives full approval to Moderna’s COVID-19 vaccine
2 years, 10 months ago
Moderna's COVID-19 vaccine receives full FDA approval for Americans aged 18 and older
2 years, 10 months ago
U.S. gives full approval to Moderna’s COVID-19 vaccine
2 years, 10 months ago
COVID-19 | Government to wait for expert view on booster dose, jabs for children
3 years ago
Key decisions on Pfizer Covid-19 vaccine boosters for all adults could come this week
3 years, 1 month ago
Pfizer says COVID-19 pill cut hospital, death risk by 90%
3 years, 1 month ago
United States gives final clearance to COVID shots for kids 5 to 11
3 years, 1 month ago
Pfizer-BioNTech covid-19 vaccine for young children to be reviewed by FDA advisers
3 years, 1 month ago
US marks 200M COVID-19 shots shared with world
3 years, 2 months ago
‘Covid vax for kids 5-11 will be at pediatric offices, schools once authorized’
3 years, 2 months ago
US to Begin Vaccinating 5-11 Year Olds Against Covid-19 From Next Month: White House
3 years, 2 months ago
CDC vaccine advisers schedule meetings to discuss booster shots, vaccines for kids
3 years, 2 months ago
Full FDA approval of Pfizer’s Covid-19 vaccine had only a modest impact on uptake. Here’s what mattered more
3 years, 2 months ago
US coronavirus: Antiviral pill could be a game changer, but vaccines are still America’s way out of the pandemic, experts say
3 years, 2 months ago
FDA backs Pfizer COVID-19 boosters for seniors, high-risk
3 years, 3 months ago
Pfizer Covid-19 vaccine: FDA authorizes booster dose for people 65 and up
3 years, 3 months ago
COVID booster use may be expanded, US health officials say
3 years, 3 months ago
U.S. panel backs COVID-19 boosters only for elderly, high-risk
3 years, 3 months ago
FDA advisers first rejected Pfizer’s booster application – but then voted to recommend a third shot for certain Americans
3 years, 3 months ago
US FDA panel okays COVID-19 booster jabs for people over 65
3 years, 3 months ago
Pfizer Vaccine Still Effective, FDA Says Days Before Review Of Booster Proposal
3 years, 3 months ago
Expect a bumpy ride this week when FDA advisers consider Covid-19 booster shots
3 years, 3 months ago
FDA experts among group opposing US booster shot plan
3 years, 3 months ago

Discover Related